I. Pathophysiology & Clinical Spectrum Ehlers-Danlos syndrome (EDS) is a heterogeneous group of inherited connective tissue disorders caused by defects in collagen synthesis, processing, or structure—most commonly COL1A1, COL1A2, COL3A1,…
Epidemiology & Pathophysiology Spina bifida (SB) is a spectrum of congenital neural tube defects (NTDs) resulting from failed or incomplete closure of the neural tube between days 26–28 post-conception. Incidence…
I. Pathophysiology and Clinical Significance Obstructive sleep apnea (OSA) is a highly prevalent, underdiagnosed, and underrecognized chronic disorder characterized by repetitive collapse of the upper airway during sleep, despite ongoing…
I. Epidemiology & Pathophysiology: Clinical Relevance Restless Legs Syndrome (RLS), or Willard-Ekbom disease, is a common sensorimotor neurologic disorder affecting ~5–10% of adults and 2–4% of children in Western populations,…
Prepared for practicing clinicians—updated to reflect 2023–2024 guidelines from the American College of Physicians (ACP), American Pain Society, North American Spine Society (NASS), Cochrane Database Reviews, and the 2024 updated…
I. Epidemiology & Pathogenesis: Beyond Surface Symptoms Acne vulgaris is a chronic, inflammatory disease of the pilosebaceous unit affecting up to 85% of adolescents and 12–24% of adult women (≤45…
I. Pathophysiology & Epidemiology: Core Clinical Concepts Androgenetic alopecia (AGA) is a genetically determined, androgen-dependent, nonscarring hair loss disorder affecting up to 50% of males by age 50 and >80%…
I. Introduction & Pathophysiology Recap Hereditary hemochromatosis (HH), most commonly HFE-related (OMIM #235200), is an autosomal recessive disorder characterized by excessive intestinal iron absorption, leading to progressive parenchymal iron deposition…
Adapted from latest guidelines (GOLD 2026, CHEST 2025, ERS/ATS 2023 updates) and recent clinical trial data (e.g., PILOT, RESOLVE, NCT03914827), this review integrates pathophysiology, diagnostic algorithm optimization, and targeted therapeutic…
Adapted from current international guidelines (AASLD 2022 Update, EASL Clinical Practice Guidelines 2023, WHO Toxic Hepatotoxicity Report 2024) and peer-reviewed literature. I. Definition and Epidemiology Acute liver failure (ALF) is…
Prepared for Clinicians | Based on 2024–2025 Guidelines from WHO, AACE, Endocrine Society, ASMBS, and ADA I. Pathophysiology and Clinical Definition: Obesity as a Chronic Relapsing Disease Obesity is now…
I. Definition & Clinical Stages: Beyond Simplistic Timeline Descriptions Menopause is not a single event but a continuum of physiological transition driven by ovarian follicular depletion and hormonal decline. A.…
I. Disease-Modifying Therapy (DMT) Indications & Goals Multiple sclerosis (MS) remains an immune-mediated demyelinating disease of the central nervous system (CNS), characterized by neuroinflammation, axonal transection, and progressive neurodegeneration. While…
Epidemiology & Clinical Burden Migraine remains one of the most prevalent neurological disorders globally, affecting ~1.3 billion individuals annually, with a 30% increase in age-standardized prevalence over the past three…
1. Definition, Epidemiology, and Classification Parkinson disease (PD) is a progressive, proteinopathic neurodegenerative disorder characterized by the selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and…
